BiotechTube
Home/Pipeline/CAR-T Lung

CAR-T Lung

Solid Tumor – Lung Cancer

Phase 1Active

Key Facts

Indication
Solid Tumor – Lung Cancer
Phase
Phase 1
Status
Active
Company
AdAlta

About AdAlta

Australian biotech delivering CAR‑T and i‑body therapies for solid tumours, fibrosis and malaria.

View full company profile

Therapeutic Areas

OncologyFibrosisInfectious Disease